| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |